Status:
UNKNOWN
Metformin for Weight Control in Adolescents Taking Atypical Antipsychotics
Lead Sponsor:
BeerYaakov Mental Health Center
Conditions:
Drug Induced Weight Gain
Eligibility:
All Genders
12-20 years
Phase:
PHASE4
Brief Summary
Atypical antipsychotics (AA) are broadly used to treat a variety of psychiatric and neurological disorders in children and adolescents. Weight gain is a common side effect of these drugs. AA induced w...
Eligibility Criteria
Inclusion
- 12-20 year olds treated by atypical antipsychotics
- weight gain of more than 10% than expected for age
- Overweight of more than 10% than expected for age and height
Exclusion
- Physical conditions requiring pharmacological treatment
- Changes in drug type or dosage 2 months before the trial, except for 25% changes in dosage
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00845936
Start Date
May 1 2009
End Date
May 1 2010
Last Update
February 19 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beer-Yaacov MHC
Beer Yaacov, Israel, 70350